Tara Fryatt

589 total citations
8 papers, 348 citations indexed

About

Tara Fryatt is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Toxicology. According to data from OpenAlex, Tara Fryatt has authored 8 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Toxicology. Recurrent topics in Tara Fryatt's work include Cancer therapeutics and mechanisms (3 papers), Phytoestrogen effects and research (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Tara Fryatt is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Phytoestrogen effects and research (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Tara Fryatt collaborates with scholars based in United Kingdom, United States and Germany. Tara Fryatt's co-authors include Nigel P. Botting, Philip B. Grace, James I. Taylor, Sheila Bingham, Mark F. Oldfield, Christopher J. Moody, Howard D. Beall, Nawaf Al‐Maharik, Stephen J. Green and Hanna Pettersson and has published in prestigious journals such as Biochemistry, Analytical Biochemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Tara Fryatt

8 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Fryatt United Kingdom 8 161 124 88 52 41 8 348
Kelsey C. Duggan United States 5 139 0.9× 38 0.3× 159 1.8× 48 0.9× 50 1.2× 6 521
Dmitry Kuklev United States 13 221 1.4× 35 0.3× 156 1.8× 22 0.4× 39 1.0× 23 595
Joel Musee United States 5 106 0.7× 24 0.2× 121 1.4× 40 0.8× 32 0.8× 5 384
Stephanie Whitman United States 11 243 1.5× 22 0.2× 164 1.9× 68 1.3× 50 1.2× 12 532
Ziping Bao United States 8 233 1.4× 31 0.3× 62 0.7× 5 0.1× 19 0.5× 12 516
Gamal A. Elmegeed Egypt 19 274 1.7× 30 0.2× 692 7.9× 89 1.7× 92 2.2× 44 1.1k
Jane A. McLaughlin United States 14 290 1.8× 23 0.2× 74 0.8× 13 0.3× 13 0.3× 25 615
Balázs Balogh Hungary 13 195 1.2× 24 0.2× 134 1.5× 10 0.2× 9 0.2× 34 441
Zhaoxing Meng China 12 147 0.9× 32 0.3× 310 3.5× 73 1.4× 9 0.2× 20 705
Dya Fita Dibwe Japan 18 448 2.8× 30 0.2× 188 2.1× 41 0.8× 20 0.5× 48 821

Countries citing papers authored by Tara Fryatt

Since Specialization
Citations

This map shows the geographic impact of Tara Fryatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Fryatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Fryatt more than expected).

Fields of papers citing papers by Tara Fryatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Fryatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Fryatt. The network helps show where Tara Fryatt may publish in the future.

Co-authorship network of co-authors of Tara Fryatt

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Fryatt. A scholar is included among the top collaborators of Tara Fryatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Fryatt. Tara Fryatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Heifetz, Alexander, Philip C. Biggin, Oliver Barker, et al.. (2012). Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis. Biochemistry. 51(15). 3178–3197. 34 indexed citations
2.
Law, Richard, Oliver Barker, John J. Barker, et al.. (2009). The multiple roles of computational chemistry in fragment-based drug design. Journal of Computer-Aided Molecular Design. 23(8). 459–473. 45 indexed citations
3.
Andersen, Ole A., D.L. Schönfeld, Brunella Felicetti, et al.. (2009). Cross-linking of protein crystals as an aid in the generation of binary protein–ligand crystal complexes, exemplified by the human PDE10a–papaverine structure. Acta Crystallographica Section D Biological Crystallography. 65(8). 872–874. 22 indexed citations
4.
Fryatt, Tara & Nigel P. Botting. (2005). The synthesis of multiply 13C‐labelled plant and mammalian lignans as internal standards for LC‐MS and GC‐MS analysis. Journal of Labelled Compounds and Radiopharmaceuticals. 48(13). 951–969. 16 indexed citations
5.
Fryatt, Tara, Hanna Pettersson, Stephen J. Green, et al.. (2004). Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1). Bioorganic & Medicinal Chemistry. 12(7). 1667–1687. 60 indexed citations
6.
Grace, Philip B., James I. Taylor, Nigel P. Botting, et al.. (2003). Quantification of isoflavones and lignans in serum using isotope dilution liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 17(12). 1350–1357. 72 indexed citations
7.
Grace, Philip B., James I. Taylor, Nigel P. Botting, et al.. (2003). Quantification of isoflavones and lignans in urine using gas chromatography/mass spectrometry. Analytical Biochemistry. 315(1). 114–121. 64 indexed citations
8.
Fryatt, Tara, et al.. (1999). Novel quinolinequinone antitumor agents: Structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1). Bioorganic & Medicinal Chemistry Letters. 9(15). 2195–2198. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026